| Primary |
| Attention Deficit/hyperactivity Disorder |
64.3% |
| Psychomotor Hyperactivity |
7.0% |
| Depression |
4.8% |
| Bipolar Disorder |
4.2% |
| Disturbance In Attention |
3.9% |
| Obsessive-compulsive Disorder |
2.6% |
| Anxiety |
2.4% |
| Sleep Disorder |
2.2% |
| Somnolence |
1.3% |
| Agitation |
1.1% |
| Hypersensitivity |
0.9% |
| Drug Dependence |
0.7% |
| Epilepsy |
0.7% |
| Hypothyroidism |
0.7% |
| Impulsive Behaviour |
0.7% |
| Narcolepsy |
0.7% |
| Tremor |
0.7% |
| Asthma |
0.4% |
| Bipolar I Disorder |
0.4% |
| Convulsion |
0.4% |
|
| Tremor |
11.0% |
| Vomiting |
9.0% |
| Weight Decreased |
8.3% |
| Tachycardia |
7.6% |
| Drug Ineffective |
6.9% |
| Depression |
6.2% |
| Psychotic Disorder |
5.5% |
| Suicidal Ideation |
4.8% |
| Wrong Technique In Drug Usage Process |
4.8% |
| Insomnia |
4.1% |
| Irritability |
4.1% |
| Psychomotor Hyperactivity |
4.1% |
| Somnolence |
3.4% |
| Weight Increased |
3.4% |
| Death |
2.8% |
| Drug Dependence |
2.8% |
| Intentional Drug Misuse |
2.8% |
| Liver Function Test Abnormal |
2.8% |
| Loss Of Consciousness |
2.8% |
| Performance Status Decreased |
2.8% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
60.2% |
| Psychomotor Hyperactivity |
7.9% |
| Bipolar Disorder |
5.6% |
| Depression |
4.6% |
| Disturbance In Attention |
3.1% |
| Pain |
2.5% |
| Anxiety |
2.1% |
| Distractibility |
1.7% |
| Off Label Use |
1.7% |
| Asthma |
1.5% |
| Convulsion |
1.3% |
| Mild Mental Retardation |
1.3% |
| Sleep Disorder |
1.3% |
| Fatigue |
0.8% |
| Insomnia |
0.8% |
| Mood Altered |
0.8% |
| Myasthenia Gravis |
0.8% |
| Narcolepsy |
0.8% |
| Drug Dependence |
0.6% |
| Epilepsy |
0.6% |
|
| Tremor |
21.5% |
| Somnolence |
8.3% |
| Tachycardia |
6.6% |
| Weight Decreased |
5.8% |
| Nausea |
5.0% |
| Vomiting |
5.0% |
| Wrong Technique In Drug Usage Process |
5.0% |
| Drug Ineffective |
4.1% |
| Psychotic Disorder |
4.1% |
| Suicide Attempt |
4.1% |
| Drug Intolerance |
3.3% |
| Insomnia |
3.3% |
| Liver Function Test Abnormal |
3.3% |
| Pancytopenia |
3.3% |
| Pharmaceutical Product Complaint |
3.3% |
| Stress |
3.3% |
| Weight Increased |
3.3% |
| Agitation |
2.5% |
| Drug Dependence |
2.5% |
| Dysentery |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.8% |
| Multiple Sclerosis |
10.8% |
| Attention Deficit/hyperactivity Disorder |
7.5% |
| Drug Use For Unknown Indication |
7.5% |
| Depression |
5.8% |
| Acne |
5.0% |
| Anxiety |
4.2% |
| Fibromyalgia |
4.2% |
| Atrial Fibrillation |
3.3% |
| Hypertension |
3.3% |
| Supplementation Therapy |
3.3% |
| Bipolar Disorder |
2.5% |
| Crohn's Disease |
2.5% |
| Insomnia |
2.5% |
| Narcolepsy |
2.5% |
| Sleep Disorder Therapy |
2.5% |
| Anticoagulant Therapy |
1.7% |
| Blood Cholesterol |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Cardiac Disorder |
1.7% |
|
| Rotator Cuff Syndrome |
14.3% |
| Drug Ineffective |
7.1% |
| Headache |
7.1% |
| Neck Pain |
7.1% |
| Suicidal Ideation |
7.1% |
| Urinary Tract Infection |
7.1% |
| Antisocial Behaviour |
3.6% |
| Anxiety |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Cervical Spinal Stenosis |
3.6% |
| Coeliac Disease |
3.6% |
| Death |
3.6% |
| Deep Vein Thrombosis |
3.6% |
| Depression |
3.6% |
| Flushing |
3.6% |
| Hallucination |
3.6% |
| Heart Rate Increased |
3.6% |
| Hypertension |
3.6% |
| Injection Site Haematoma |
3.6% |
| Intestinal Haemorrhage |
3.6% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
40.0% |
| Cough |
20.0% |
| Pyrexia |
20.0% |
| Sleep Disorder |
20.0% |
|
| Body Temperature Increased |
66.7% |
| Drug Interaction |
33.3% |
|
